Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan

Cheng Han Lee, Ping Yen Liu, Li Jen Lin, Jyh Hong Chen, Liang Miin Tsai

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives: The aim of this study was to analyze clinical characteristics and the outcome of patients with apical hypertrophic cardiomyopathy (ApHCM) followed in a Taiwan tertiary referral medical center. Background: ApHCM is regarded as a subgroup of nonobstructive HCM that occurs largely in Japanese patients. The clinical features, gender differences and prognosis of the disease in Taiwan are poorly understood. Methods: A retrospective cohort study with 40 patients was performed. Diagnosis was based on the demonstration of left ventricular hypertrophy by echocardiography. Clinical features, cardiovascular morbidity and mortality were analyzed. Multiple logistic regression was used to adjust for potential confounding factors. Results: Among 40 patients, males predominated with a percentage of 75%. The female patients obviously had later onset of presentation (mean age ± SD, 62.2 ± 5.7 vs. 54.1 ± 11.4 years; p = 0.038). During a mean follow-up of 72.2 ± 60.1 months, there was no mortality. However, 13 patients (32.5%) had one or more major cardiovascular morbidities, the most frequent being syncope or near syncope (15%) and ischemic stroke-associated atrial fibrillation (10%). In a multivariate analysis, left atrial enlargement (odds ratio 5.85, 95% CI 1.15-29.40; p = 0.034) was the only predictor of cardiovascular morbidity. Conclusions: Patients with ApHCM in Taiwan have a benign clinical course without association with sudden death and cardiovascular mortality. Left atrial enlargement was the only identified predictor of cardiovascular morbidity

Original languageEnglish
Pages (from-to)29-35
Number of pages7
JournalCardiology
Volume106
Issue number1
DOIs
Publication statusPublished - 2006 Jun 1

Fingerprint

Hypertrophic Cardiomyopathy
Taiwan
Morbidity
Syncope
Mortality
Left Ventricular Hypertrophy
Sudden Death
Tertiary Care Centers
Atrial Fibrillation
Echocardiography
Cohort Studies
Multivariate Analysis
Retrospective Studies
Logistic Models
Stroke
Odds Ratio

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

Lee, Cheng Han ; Liu, Ping Yen ; Lin, Li Jen ; Chen, Jyh Hong ; Tsai, Liang Miin. / Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan. In: Cardiology. 2006 ; Vol. 106, No. 1. pp. 29-35.
@article{6d740668bc044a17ab747f069f3046ad,
title = "Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan",
abstract = "Objectives: The aim of this study was to analyze clinical characteristics and the outcome of patients with apical hypertrophic cardiomyopathy (ApHCM) followed in a Taiwan tertiary referral medical center. Background: ApHCM is regarded as a subgroup of nonobstructive HCM that occurs largely in Japanese patients. The clinical features, gender differences and prognosis of the disease in Taiwan are poorly understood. Methods: A retrospective cohort study with 40 patients was performed. Diagnosis was based on the demonstration of left ventricular hypertrophy by echocardiography. Clinical features, cardiovascular morbidity and mortality were analyzed. Multiple logistic regression was used to adjust for potential confounding factors. Results: Among 40 patients, males predominated with a percentage of 75{\%}. The female patients obviously had later onset of presentation (mean age ± SD, 62.2 ± 5.7 vs. 54.1 ± 11.4 years; p = 0.038). During a mean follow-up of 72.2 ± 60.1 months, there was no mortality. However, 13 patients (32.5{\%}) had one or more major cardiovascular morbidities, the most frequent being syncope or near syncope (15{\%}) and ischemic stroke-associated atrial fibrillation (10{\%}). In a multivariate analysis, left atrial enlargement (odds ratio 5.85, 95{\%} CI 1.15-29.40; p = 0.034) was the only predictor of cardiovascular morbidity. Conclusions: Patients with ApHCM in Taiwan have a benign clinical course without association with sudden death and cardiovascular mortality. Left atrial enlargement was the only identified predictor of cardiovascular morbidity",
author = "Lee, {Cheng Han} and Liu, {Ping Yen} and Lin, {Li Jen} and Chen, {Jyh Hong} and Tsai, {Liang Miin}",
year = "2006",
month = "6",
day = "1",
doi = "10.1159/000092590",
language = "English",
volume = "106",
pages = "29--35",
journal = "Cardiology",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "1",

}

Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan. / Lee, Cheng Han; Liu, Ping Yen; Lin, Li Jen; Chen, Jyh Hong; Tsai, Liang Miin.

In: Cardiology, Vol. 106, No. 1, 01.06.2006, p. 29-35.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan

AU - Lee, Cheng Han

AU - Liu, Ping Yen

AU - Lin, Li Jen

AU - Chen, Jyh Hong

AU - Tsai, Liang Miin

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Objectives: The aim of this study was to analyze clinical characteristics and the outcome of patients with apical hypertrophic cardiomyopathy (ApHCM) followed in a Taiwan tertiary referral medical center. Background: ApHCM is regarded as a subgroup of nonobstructive HCM that occurs largely in Japanese patients. The clinical features, gender differences and prognosis of the disease in Taiwan are poorly understood. Methods: A retrospective cohort study with 40 patients was performed. Diagnosis was based on the demonstration of left ventricular hypertrophy by echocardiography. Clinical features, cardiovascular morbidity and mortality were analyzed. Multiple logistic regression was used to adjust for potential confounding factors. Results: Among 40 patients, males predominated with a percentage of 75%. The female patients obviously had later onset of presentation (mean age ± SD, 62.2 ± 5.7 vs. 54.1 ± 11.4 years; p = 0.038). During a mean follow-up of 72.2 ± 60.1 months, there was no mortality. However, 13 patients (32.5%) had one or more major cardiovascular morbidities, the most frequent being syncope or near syncope (15%) and ischemic stroke-associated atrial fibrillation (10%). In a multivariate analysis, left atrial enlargement (odds ratio 5.85, 95% CI 1.15-29.40; p = 0.034) was the only predictor of cardiovascular morbidity. Conclusions: Patients with ApHCM in Taiwan have a benign clinical course without association with sudden death and cardiovascular mortality. Left atrial enlargement was the only identified predictor of cardiovascular morbidity

AB - Objectives: The aim of this study was to analyze clinical characteristics and the outcome of patients with apical hypertrophic cardiomyopathy (ApHCM) followed in a Taiwan tertiary referral medical center. Background: ApHCM is regarded as a subgroup of nonobstructive HCM that occurs largely in Japanese patients. The clinical features, gender differences and prognosis of the disease in Taiwan are poorly understood. Methods: A retrospective cohort study with 40 patients was performed. Diagnosis was based on the demonstration of left ventricular hypertrophy by echocardiography. Clinical features, cardiovascular morbidity and mortality were analyzed. Multiple logistic regression was used to adjust for potential confounding factors. Results: Among 40 patients, males predominated with a percentage of 75%. The female patients obviously had later onset of presentation (mean age ± SD, 62.2 ± 5.7 vs. 54.1 ± 11.4 years; p = 0.038). During a mean follow-up of 72.2 ± 60.1 months, there was no mortality. However, 13 patients (32.5%) had one or more major cardiovascular morbidities, the most frequent being syncope or near syncope (15%) and ischemic stroke-associated atrial fibrillation (10%). In a multivariate analysis, left atrial enlargement (odds ratio 5.85, 95% CI 1.15-29.40; p = 0.034) was the only predictor of cardiovascular morbidity. Conclusions: Patients with ApHCM in Taiwan have a benign clinical course without association with sudden death and cardiovascular mortality. Left atrial enlargement was the only identified predictor of cardiovascular morbidity

UR - http://www.scopus.com/inward/record.url?scp=33745727901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745727901&partnerID=8YFLogxK

U2 - 10.1159/000092590

DO - 10.1159/000092590

M3 - Article

C2 - 16612066

AN - SCOPUS:33745727901

VL - 106

SP - 29

EP - 35

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 1

ER -